文献速递肾癌与肾肿瘤

局部肾癌复发管理的系统综述

Systematic Review of the Management of Local Kidney Cancer Relapse.
PubMed 文献 · Eur Urol Oncol · 2018-07-13

本系统综述检索2000至2017年英文文献,最终纳入36项研究,多数为回顾性非对照研究。局部复发治疗因临床病程和既往治疗而异:热消融后复发可重复热消融或行挽救性肾切除术,后者并发症率高于初次肾切除术;肾部分切除术后复发可选挽救性肾切除或热消融;根治性肾切除术后局部腹膜后复发理想治疗为手术切除,大复发可加术中放疗。

要点

  • 热消融后局部复发可重复热消融或行挽救性肾切除,后者并发症率高于初次肾切除。
  • 肾部分切除术后局部复发可选挽救性肾切除或热消融。
  • 根治性肾切除术后局部腹膜后复发理想治疗为手术切除,大复发可加术中放疗。

核心结论

  • 局部肾癌复发的管理因临床病程和既往治疗而异。
  • 现有数据主要限于非对照回顾性系列。
  • 保肾治疗后,热消融是一种有效且低并发症的治疗。
  • 根治性肾切除术后局部复发,低水平证据提示手术切除优于全身治疗或最佳支持治疗。
  • 因此,在可行和适用时应优先选择手术。

研究设计与样本

  • 系统综述,遵循系统综述和Meta分析优先报告条目指南,检索PubMed、Web of Science、CINAHL、Clinical Trials和Scopus中2000至2017年的英文文献。
  • 初检识别1838篇文章,最终36篇纳入证据合成。
  • 纳入研究多数为回顾性且非对照。

主要发现

  • 热消融后局部复发可用重复热消融管理,也可行挽救性肾切除,但后者并发症率预期高于初次肾切除术后。
  • 挽救性肾切除和热消融是肾部分切除术后局部复发的治疗选择。
  • 根治性肾切除术后局部腹膜后复发理想治疗为手术切除,微创入路可能适用于选择患者。
  • 对于大复发,加用术中放疗可能改善局部控制。
  • 对于局部复发,局部肿瘤毁损似乎比单纯全身治疗更有益。

临床怎么用

  • 保肾治疗后局部复发,热消融为有效治疗且并发症率低。
  • 根治性肾切除术后局部复发,在可行和适用时应优先选择手术切除。
  • 大复发可加用术中放疗以可能改善局部控制。
  • 局部肿瘤毁损似乎比单纯全身治疗更有益。

局限性

  • 多数研究为回顾性且非对照。
  • 现有数据主要限于非对照回顾性系列。
  • 根治性肾切除术后局部复发的证据水平低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Management of locally recurrent renal cancer is complex. OBJECTIVE: In this systematic review we analyse the available literature on the management of local renal cancer recurrence. EVIDENCE ACQUISITION: A systematic search (PubMed, Web of Science, CINAHL, Clinical Trials, and Scopus) of English literature from 2000 to 2017 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. EVIDENCE SYNTHESIS: The search identified 1838 articles. Of those, 36 were included in the evidence synthesis. The majority of the studies identified were retrospective and not controlled. Local recurrence after thermal ablation (TA) may be managed with repeat TA. Alternatively, salvage nephrectomy is possible. However, a higher rate of complications should be expected than after primary nephrectomy. Salvage nephrectomy and TA represent treatment options for local recurrence after partial nephrectomy. Local retroperitoneal recurrence after radical nephrectomy is ideally treated with surgical resection, for which minimally invasive approaches might be applicable to select patients. For large recurrences, addition of intraoperative radiation may improve local control. Local tumour destruction appears to be more beneficial than systemic therapy alone for local recurrences. CONCLUSIONS: Management of local renal cancer relapse varies according to the clinical course and prior treatments. The available data are mainly limited to noncontrolled retrospective series. After nephron-sparing treatment, TA represents an effective treatment with low morbidity. For local recurrence after radical nephrectomy, the low-level evidence available suggests superiority of surgical excision relative to systemic therapy or best supportive care. As a consequence, surgery should be prioritised when feasible and applicable. PATIENT SUMMARY: In renal cell cancer, the occurrence and management of local recurrence depend on the initial treatment. This cancer is a disease with a highly variable clinical course. After initial organ-sparing treatment, thermal ablation offers good cancer control and low rates of complications. For recurrence after radical nephrectomy, surgical excision seems to provide the best long-term cancer control and it is superior to medical therapy alone.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Kriegmair MC, Bertolo R, Karakiewicz PI, et al. Systematic Review of the Management of Local Kidney Cancer Relapse. Eur Urol Oncol. 2018. PMID: 31158097. doi:10.1016/j.euo.2018.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。